Haemostatic and fibrinolytic factors in men with a small abdominal aortic aneurysm

British Journal of Surgery

Volumn 96, Issue 8, 2009, Pages 870-877

  Parry, D J ^a   Al Barjas, H S ^a   Chappell, L ^a   Rashid, T ^a,b   Ariens R A S ^b   Scott, D J A ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRINOGEN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ABDOMINAL AORTA ANEURYSM; AGED; AORTA; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; ULTRASOUND;

AGED; ANTITHROMBIN III; AORTIC ANEURYSM, ABDOMINAL; CARDIOVASCULAR DISEASES; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MALE; PEPTIDE HYDROLASES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 68049099268     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6632     Document Type: Article

References (39)

1. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360: 1531-1539.
2. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 2004; 364: 843-848.
3. Registrar General. Mortality Statistics. Cause. Review of the Registrar General on Deaths by Cause, Sex and Age in England and Wales, 2005. Series DH2 No. 32, 98. Office for National Statistics: London, 2006.
4. Brady AR, Fowkes FG, Greenhalgh RM, Powell JT, Ruckley CV, Thompson SG. Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. On behalf of the UK Small Aneurysm Trial participants. Br J Surg 2000; 87: 742-749.
5. Axelrod DA, Diwan A, Stanley JC, Jacobs LA, Henke PK, Greenfield LJ et al. Cost of routine screening for carotid and lower extremity occlusive disease in patients with abdominal aortic aneurysms. J Vasc Surg 2002; 35: 754-758.
6. Newman AB, Arnold AM, Burke GL, O'Leary DH, Manolio TA. Cardiovascular disease and mortality in older adults with small abdominal aortic aneurysms detected by ultrasonography: the cardiovascular health study. Ann Intern Med 2001; 134: 182-190.
7. Norman P, Le M, Pearce C, Jamrozik K. Infrarenal aortic diameter predicts all-cause mortality. Arterioscler Thromb Vasc Biol 2004; 24: 1278-1282.
8. Brady AR, Fowkes FG, Thompson SG, Powell JT. Aortic aneurysm diameter and risk of cardiovascular mortality. Arterioscler Thromb Vasc Biol 2001; 21: 1203-1207.
9. Stenbaek J, Kalin B, Swedenborg J. Growth of thrombus may be a better predictor of rupture than diameter in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2000; 20: 466-469.
10. Adolph R, Vorp DA, Steed DL, Webster MW, Kameneva MV, Watkins SC. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg 1997; 25: 916-926.
11. Fontaine V, Jacob MP, Houard X, Rossignol P, Plissonnier D, Angles-Cano E et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002; 161: 1701-1710.
12. Touat Z, Ollivier V, Dai J, Huisse MG, Bezeaud A, Sebbag U et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 2006; 168: 1022-1030.
13. Houard X, Rouzet F, Touat Z, Philippe M, Dominguez M, Fontaine V et al. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol 2007; 212: 20-28.
14. Yamazumi K, Ojiro M, Okumura H, Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg 1998; 175: 297-301.
15. Nomura F, Ihara A, Yoshitatsu M, Tamura K, Katayama A, Ihara K. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm. Eur J Cardiothorac Surg 2003; 23: 1034-1038.
16. Ihara A, Kawamoto T, Matsumoto K, Kawamoto J, Katayama A, Yoshitatsu M et al. Relationship between hemostatic markers and circulating biochemical markers of collagen metabolism in patients with aortic aneurysm. Pathophysiol Haemost Thromb 2003; 33: 221-224.
17. Hosaka A, Miyata T, Aramoto H, Shigematsu H, Nakazawa T, Okamoto H et al. Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm. J Vasc Surg 2005; 42: 200-205.
18. Aramoto H, Shigematsu H, Muto T. Perioperative changes in coagulative and fibrinolytic function during surgical treatment of abdominal aortic aneurysm and arteriosclerosis obliterans. Int J Cardiol 1994; 47(Suppl): S55-S63.
19. Holmberg A, Bergqvist D, Siegbahn A. Coagulation and fibrinolysis after open infrarenal abdominal aortic aneurysm repair in a long-term perspective. Thromb Res 1999; 96: 99-105.
20. Fowkes FG, Anandan CL, Lee AJ, Smith FB, Tzoulaki I, Rumley A et al. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease. J Vasc Surg 2006; 43: 474-480.
21. Haverkate F. Levels of haemostatic factors, arteriosclerosis and cardiovascular disease. Vasc Pharmacol 2002; 39: 109-112.
22. Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl AK et al. Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease. Thromb Haemost 2006; 95: 702-707.
23. Giannitsis E, Siemens HJ, Mitusch R, Tettenborn I, Wiegand U, Schmücker G et al. Prothrombin fragments F1 + 2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis. Int J Cardiol 1999; 68: 269-274.
24. Hioki H, Aoki N, Kawano K, Homori M, Hasumura Y, Yasumura T et al. Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 2001; 22: 56-61.
25. Alessandri C, Basili S, Maurelli M, Bracaglia D, Andreozzi P, Pergolini M et al. Relationship between prothrombin activation fragment F1 + 2 and serum cholesterol. Haemostasis 1996; 26: 214-219.
26. Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes 2006; 55: 1807-1812.
27. Lowe GD, Sweetnam PM, Yarnell JW, Rumley A, Rumley C, Bainton D et al. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies. Arterioscler Thromb Vasc Biol 2004; 24: 1957-1962.
28. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993; 118: 956-963.
29. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001; 103: 2323-2327.
30. Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-1097.
31. Lee AJ, Fowkes FG, Lowe GD, Rumley A. Haemostatic factors, atherosclerosis and risk of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 1996; 7: 695-701.
32. Al-Barjas HS, Ariëns RA, Grant P, Scott JA. Raised fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology 2006; 57: 607-613.
33. Falkenberg M, Holmdahl L, Tjärnstrom J, Risberg B. Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms. Eur J Surg 2001; 167: 10-14.
34. Wanhainen A, Nilsson TK, Bergqvist D, Boman K, Björck M. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm. J Vasc Surg 2007; 45: 1109-1113.
35. Golledge J,Wolanski P, Parr A, Buttner P. Measurement and determinants of infrarenal aortic thrombus volume. Eur Radiol 2008; 18: 1987-1994.
36. Salsac AV, Sparks SR, Lasheras JC. Hemodynamic changes occurring during the progressive enlargement of abdominal aortic aneurysms. Ann Vasc Surg 2004; 18: 14-21.
37. Woodburn KR, Lowe GD, Rumley A, Love J, Pollock JG. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease. Int Angiol 1995; 14: 346-352.
38. Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D et al. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 2006; 26: 2793-2799.
39. Patterson C, Stouffer GA, Madamanchi N, Runge MS. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 2001; 88: 987-997.